Dehydrodiisoeugenol, an isoeugenol dimer, inhibits lipopolysaccharide-stimulated nuclear factor kappa B activation and cyclooxygenase-2 expression in macrophages
- Arch Biochem Biophys. 2005 Feb 15;434(2):326-32. doi: 10.1016/j.abb.2004.11.013.
- 1. Department of Oral Diagnosis, Meikai University School of Dentistry, 1-1 Keyakidai, Sakado City, Saitama 350-0283, Japan.
o-Methoxyphenols such as eugenol and isoeugenol exhibit anti-oxidant and anti-inflammatory activities, but at higher concentrations act as oxidants and potent allergens. We recently demonstrated the eugenol dimer bis-eugenol to be an efficient inhibitor of lipopolysaccharide (LPS)-induced inflammatory cytokine expression in macrophages without cytotoxicity. This result suggested that dimer compound of o-methoxyphenols may possess anti-inflammatory activity. Thus, we further synthesized dehydrodiisoeugenol and alpha-diisoeugenol from isoeugenols, and investigated whether these dimers could inhibit LPS-stimulated nuclear factor kappa B (NF-kappaB) activation and cyclooxygenase (COX)-2 gene expression, both of which are closely involved in inflammation and mutagenesis. The expression of the COX-2 gene was strongly inhibited by dehydrodiisoeugenol in RAW264.7 murine macrophages stimulated with LPS. In contrast, isoeugenol and alpha-diisoeugenol did not inhibit it. Dehydrodiisoeugenol also significantly inhibited LPS-stimulated phosphorylation-dependent proteolysis of inhibitor kappaB-alpha and transcriptional activity of NF-kappaB in the cells. These findings suggest that dehydrodiisoeugenol acts as a potent anti-inflammatory agent.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: NF-κB; COX; Apoptosis; Autophagy; NO Synthase; PERK; JNK; p38 MAPK; CDK; NOD-like Receptor (NLR)
-
target: PERK; Autophagy; NF-κB; p38 MAPK; CDK; NOD-like Receptor (NLR); NO Synthase; Apoptosis; JNK; Isotope-Labeled Compounds; COX
-
target: PERK; Autophagy; NF-κB; Reference Standards; p38 MAPK; CDK; NOD-like Receptor (NLR); NO Synthase; Apoptosis; JNK; COX